• Please log in or register to access this feature.

Liver Failure and Liver Disease

You have full text access to this OnlineOpen article

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites

  1. Francesco Salerno1,†,*,
  2. Manuela Merli2,
  3. Oliviero Riggio2,
  4. Massimo Cazzaniga1,
  5. Valentina Valeriano2,
  6. Massimo Pozzi3,
  7. Antonio Nicolini4,
  8. Filippo Salvatori5

Article first published online: 30 AUG 2004

DOI: 10.1002/hep.20364

Issue

Hepatology

Hepatology

Volume 40, Issue 3, pages 629–635, September 2004

Additional Information

How to Cite

Salerno, F., Merli, M., Riggio, O., Cazzaniga, M., Valeriano, V., Pozzi, M., Nicolini, A. and Salvatori, F. (2004), Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology, 40: 629–635. doi: 10.1002/hep.20364

Author Information

  1. 1

    Department of Internal Medicine, University and Ospedale Maggiore Policlinico Instituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Milan, Italy

  2. 2

    Department of Gastroenterology, University “La Sapienza and Policlinico “Umberto I”, Rome, Italy

  3. 3

    Department of Internal Medicine, 2nd University of Milan, Ospedale San Gerardo, Monza, Italy

  4. 4

    Radiology Unit, Ospedale Maggiore Policlinico Instituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Milan, Italy

  5. 5

    Department of Radiology, Policlinico “Umberto I”, Rome, Italy

  1. †

    fax: +39 02 50320748

*Department of Internal Medicine, Via Pace, 9, 20122 Milan, Italy

  1. †

    fax: +39 02 50320748

  2. GIST = Gruppo Italiano per lo Studio TIPS.

Publication History

  1. Issue published online: 30 AUG 2004
  2. Article first published online: 30 AUG 2004
  3. Manuscript Accepted: 7 MAY 2004
  4. Manuscript Received: 12 FEB 2004

Funded by

  • Ministero dell'Università Italiana
  • Ospedale Maggiore Policlinico Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Milan

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (130K)

References

  • 1
    Orloff MJ. Pathogenesis and surgical treatment of intractable ascites associated with alcoholic cirrhosis. Ann N Y Acad Sci 1970; 170: 330–337.
    Direct Link:
  • 2
    Ochs A, Rössle M, Haag, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192–1197.
  • 3
    Quiroga J, Sangro B, Nuñez M, Bilbao I, Longo J, Garcia-Villareal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascite: effect on clinical, renal, humoral and hemodynamic parameters. HEPATOLOGY 1995; 21: 986–994.
  • 4
    Wong F, Sniderman K, Liu P, Allidina J, Sherman M, Blendis L. Transjugular intrahepatic portosystemic shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122: 816–822.
  • 5
    Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. HEPATOLOGY 1998; 28: 683–688.
    Direct Link:
  • 6
    Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites. J Hepatol 1996; 25: 135–144.
  • 7
    Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Eng J Med 2000; 342: 1701–1707.
  • 8
    Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Ruiz Del Arbol L, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839–1847.
  • 9
    Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al., and the NASTRA Group. The North American study for the treatment of refractory ascites. Gastroenterology 2003; 124: 634–641.
  • 10
    Conn HO, Lieberthal MM. The hepatic coma syndromes and lactulose. Baltimore: Williams & Wilkins, 1979.
  • 11
    Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Eng J Med 1989; 321: 1632–1638.
  • 12
    Llach J, Ginès P, Arroyo V, Rimola A, Titò L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to hospital for the treatment of ascites. Gastroenterology 1988; 94: 482–487.
  • 13
    Arroyo V, Ginès P, Gerbes AL, Dudlej FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. HEPATOLOGY 1996; 23: 164–176.
    Direct Link:
  • 14
    Salerno F, Badalamenti S, Incerti P, Tampini S, Restelli B, Bruno S, et al. Repeated paracentesis and iv albumin infusion to treat “tense” ascites in cirrhotic patients: a safe alternative therapy. J Hepatol 1987; 5: 102–108.
  • 15
    Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. HEPATOLOGY 1998; 27: 48–53.
    Direct Link:
  • 16
    Salerno F, Borroni G, Moser P, Badalamenti S, Cassarà L, Maggi A, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88: 514–519.
  • 17
    Ginès A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with tense ascites treated by paracentesis. Gastroenterology 1996; 111: 1002–1010.
  • 18
    Ginès P, Tito LL, Arroyo V, Planas R, Panès J, Vives J, et al. Randomized comparative study of paracentesis with and without albumin in cirrhosis. Gastroenterology 1988; 94: 1493–1502.
  • 19
    Allard JP, Chau J, Sandokji K, Blendis LM, Wong F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001; 96: 2442–2447.
    Direct Link:
  • 20
    Kamath P, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464–470.
    Direct Link:
  • 21
    Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt : ePTFE-covered stentgrafts versus bare tsents. HEPATOLOGY 2003; 38: 1043–1050.
View Full Article (HTML) Get PDF (130K)